Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,033,908
+$117,818 QoQ
Shares Held
862
-13.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#3,121
of 4,605 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Faithward Advisors, LLC holds $6,902,856 across 7 Drug Manufacturers - General names. LLY ranks #4 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,824 | $1,987,061 | |
| 2 | ABBV |
AbbVie Inc.
|
6,192 | $1,558,154 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,353 | $1,201,860 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
862 | $1,033,908 | |
| 5 | AMGN |
Amgen Inc
|
1,269 | $459,530 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,229 | $407,951 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,415 | $254,392 |
All Filings in LLY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,033,908 | 862 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $916,090 | 996 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $968,286 | 901 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $219,744 | 288 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $282,969 | 363 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $569,659 | 643 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $554,092 | 612 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $486,225 | 625 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||